-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Karuna Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2018 to Q4 2023.
- Karuna Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2023 was $16.4M, a 69.2% increase year-over-year.
- Karuna Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2023 was $61.8M, a 319% increase year-over-year.
- Karuna Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $61.8M, a 319% increase from 2022.
- Karuna Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $14.8M, a 27230% increase from 2021.
- Karuna Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $54K, a 98.4% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)